(19)
(11) EP 1 469 889 A2

(12)

(88) Date of publication A3:
13.11.2003

(43) Date of publication:
27.10.2004 Bulletin 2004/44

(21) Application number: 03731800.3

(22) Date of filing: 23.01.2003
(51) International Patent Classification (IPC)7: A61K 48/00, A61P 3/10
(86) International application number:
PCT/IB2003/000597
(87) International publication number:
WO 2003/061551 (31.07.2003 Gazette 2003/31)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR
Designated Extension States:
AL LT LV MK RO

(30) Priority: 23.01.2002 US 350783 P

(71) Applicants:
  • Aegera Therapeutics Inc.
    Verdun,Quebec H3E 1A8 (CA)
  • THE UNIVERSITY OF BRITISH COLUMBIA
    Vancouver,British Columbia V6T 1Z3 (CA)

(72) Inventors:
  • VERCHERE, Bruce
    Vancouver, British Columbia V5Z 1Z7 (CA)
  • TAN, Rusung
    Vancouver, British Columbia V6M 2C9 (CA)
  • LISTON, Peter
    Ottawa, Ontario K1S 2H2 (CA)
  • KORNELUK, Robert, G.
    Ottawa, Ontario K1G 2L8 (CA)

(74) Representative: Steinecke, Peter, Dr. 
Müller Fottner Steinecke,P.O. Box 31 01 40
80102 München
80102 München (DE)

   


(54) EX-VIVO GENE THERAPY OF DIABETES USING IAP POLYPEPTIDES